<code id='0A4786D440'></code><style id='0A4786D440'></style>
    • <acronym id='0A4786D440'></acronym>
      <center id='0A4786D440'><center id='0A4786D440'><tfoot id='0A4786D440'></tfoot></center><abbr id='0A4786D440'><dir id='0A4786D440'><tfoot id='0A4786D440'></tfoot><noframes id='0A4786D440'>

    • <optgroup id='0A4786D440'><strike id='0A4786D440'><sup id='0A4786D440'></sup></strike><code id='0A4786D440'></code></optgroup>
        1. <b id='0A4786D440'><label id='0A4786D440'><select id='0A4786D440'><dt id='0A4786D440'><span id='0A4786D440'></span></dt></select></label></b><u id='0A4786D440'></u>
          <i id='0A4786D440'><strike id='0A4786D440'><tt id='0A4786D440'><pre id='0A4786D440'></pre></tt></strike></i>

          explore

          explore

          author:knowledge    Page View:252

          What does Covid-19 have in store for the winter? When are good data not good enough? And how many would-be Wegovys are there?

          We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Helen Branswell joins us to discuss the state of the Covid-19 pandemic heading into the fall and the rollout of boosters shots aimed at the latest viral variants. We also discuss the latest news in the life sciences, including an IPO implosion, a debate at the FDA, and the ups and downs of a career in biotech.

          advertisement

          For more on what we cover, here’s the latest on booster shots; here’s more on Covid-19 in 2023; here’s the news on Alnylam Pharmaceuticals; here’s more on 2Seventy Bio; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

          Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

          And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

          advertisement

          explore

          Medicare details structure of new drug price negotiation program
          Medicare details structure of new drug price negotiation program

          MedicareonFridayreleasednewdetailsabouthowitsnewdrugpricenegotiationprogramwillwork,justtwomonthsbef

          read more
          Listen: A conversation with researcher Kevin Esvelt on biosecurity
          Listen: A conversation with researcher Kevin Esvelt on biosecurity

          Ifyouaskachatbothowtocauseapandemic,itwillsuggestthe1918influenzavirus,accordingtoresearcherKevinEsv

          read more
          Psychedelics group wrestles with new pharma identity
          Psychedelics group wrestles with new pharma identity

          OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

          read more

          Liver decline slowed by off

          AdobeWASHINGTON—TherearethreeFDA-approveddrugsfortreatingalcoholusedisorder.Butadifferentmedication,